Archives
-
RHEB Neddylation Links UBE2F to Liver Tumorigenesis
2026-09-07
The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation machinery and maps the modification to lysine 169. By connecting RHEB neddylation with lysosomal localization, GTP loading, mTORC1 activation, and liver tumorigenesis, the work provides a mechanistic explanation for how aberrant neddylation can intensify PTEN-loss-associated liver disease.
-
Selective Autophagy Tunes IRF3 Stability and IFN
2026-09-05
Wu and colleagues show that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus load-dependent manner, while PSMD14 preserves IRF3 by removing K27-linked ubiquitin chains at lysine 313. The work defines a regulatory axis that balances type I interferon production with immune suppression and provides a framework for studying transcription-factor stability during antiviral signaling.
-
Ertapenem in Translational Resistance Research
2026-09-04
A mechanistic and translational framework for using Ertapenem sodium salt to connect PBP biology, phenotype testing, carbapenemase transmission, and resistance research strategy.
-
X-press Tag Peptide for Reliable Protein Assays
2026-09-04
This scenario-driven guide explains how X-press Tag Peptide (SKU A6010) can strengthen recombinant-protein preparation for cell viability, proliferation, and cytotoxicity studies. It connects documented composition, solubility, affinity options, and storage requirements with practical controls for interpreting biology-driven assay changes.
-
WNT5a/GSK3/β-Catenin Control of Muscle FAPs
2026-09-03
This study identifies the WNT5a/GSK3/β-catenin axis as a previously underappreciated regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, network modeling, and transcriptomic datasets, the authors connect β-catenin stabilization with reduced fat accumulation and improved FAP support of muscle regeneration.
-
Panobinostat (LBH589): Reliable Cell Assays
2026-09-03
This scenario-based guide explains how Panobinostat (LBH589), SKU A8178, can support more interpretable viability, proliferation, and apoptosis experiments. It combines product-specific handling data with current evidence on HDAC biology and RNA polymerase II-linked cell death signaling.
-
BML-277: Mapping the Chk2–cGAS Checkpoint
2026-09-02
BML-277 is a potent Chk2 inhibitor for dissecting DNA damage signaling beyond simple kinase readouts. This article explains how to use it to test the CHK2–cGAS–TRIM41 pathway while separating biochemical inhibition, T-cell radioprotection, and L1 retrotransposition phenotypes.
-
Tin Mesoporphyrin IX: HO Assay Strategy
2026-09-02
Tin Mesoporphyrin IX (chloride) is a nanomolar competitive heme oxygenase inhibitor for mechanistic studies of heme catabolism, redox biology, and metabolic disease research. This article shows how to use C5606 to distinguish HO-dependent effects from downstream antiviral and cellular phenotypes.
-
HotStart Universal 2X Green qPCR Master Mix Workflow
2026-09-01
Build a reproducible RT-qPCR workflow for diet-intervention studies, including finishing-pig assays that connect tissue gene expression with meat-quality and microbiota findings. This guide combines hot-start specificity, Green I fluorescence, ROX normalization, melt-curve verification, and practical troubleshooting for reliable gene expression quantification.
-
ATP Solution for mRNA-LNP Research
2026-09-01
ATP Solution (100 mM) supports reproducible kinase, transcription, ligation, and phosphorylation workflows that underpin mRNA-LNP development. This guide connects precise ATP handling with the localized p21 mRNA-LNP strategy reported for bladder cancer while separating upstream assay support from therapeutic evidence.
-
LDH Cytotoxicity Assay Kit: Workflow & QC
2026-08-31
The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive colorimetric approach for cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is intended for comparative in vitro studies, not for assigning a specific death pathway, in vivo testing, or clinical diagnosis.
-
Dabigatran Etexilate: Oral Thrombin Inhibition
2026-08-31
This clinical review examines dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing its rapid, predictable anticoagulant activity and reduced dependence on INR monitoring. Its prodrug conversion, renal clearance, efficacy across thromboembolic settings, and bleeding-related limitations remain central to interpreting its clinical role.
-
Humanized Mice Clarify HD56 Prodrug Exposure
2026-08-30
The 2025 reference study shows that humanized-liver mice can resolve species-dependent metabolism of the CES-activated prodrug HD56 and improve prediction of its conversion to HD561. Its strong in vivo–in vitro correlation highlights why human-relevant metabolic models are valuable when conventional animal data are difficult to translate.
-
Graphene-Induced Apoptosis in Melanoma Cells
2026-08-29
The reference study shows that graphene film suppresses B16F10 melanoma-cell proliferation while engaging intrinsic apoptosis, oxidative stress, and G0/G1 cell-cycle arrest. Its combination of transcriptomics, biochemical readouts, and caspase-inhibitor rescue experiments provides a useful framework for interpreting how nanomaterial exposure reshapes melanoma cell-death programs.
-
RHEB Neddylation Links UBE2F to Liver Tumorigenesis
2026-08-28
The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation machinery and maps the functionally important modification to K169. By connecting this modification with lysosomal RHEB localization, GTP binding, mTORC1 activation, and PTEN-loss-driven liver tumorigenesis, the work establishes a mechanistic link between neddylation and oncogenic nutrient signaling.